ATOS ▼ -0.9% - Atossa Therapeutics, Inc. $ATOS ATOS - Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Aging 24-SEP-2026 08:01 AM ET